Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Brooks Introduces Next-Generation Automated Sample Storage Systems

Published: Wednesday, January 22, 2014
Last Updated: Wednesday, January 22, 2014
Bookmark and Share
Feature-rich, flexible, reliable technology in a standardized platform.

Brooks Life Science Systems has introduced its next-generation of automated systems for sample and biological storage.

The systems include standardized control software that offers a best-in-class user experience. The company also launched its new “Ask Brooks” expert services portal.

The announcements were made at the Society for Lab Automation and Screening’s 2014 annual conference.

“Our next-generation automated storage systems establish new industry standards for flexibility and reliability,” said Christopher McNary, vice president and chief commercial officer, Brooks Life Science Systems. “We’ve drawn upon the best technologies developed over Brooks’ 15 years of automated storage market leadership to design a storage platform that is highly adaptable to customer needs over the lifetime of the system.”

The flexibility in Brooks’ new sample storage platform comes from its modular architecture and control software. Each system has six bays that can be populated with the industry’s widest range of modules for picking, imaging, and input/output functions.

Additional sample banks can be added to the initial system via an internal bridge for future expansion. The control software offers simplified operation and installation. This versatility makes the platform easy to configure and operate, plus highly scalable to meet changing customer requirements.

“We’re leveraging Brooks’ long history in the semiconductor industry where highly reliable products have been a standard requirement for decades,” said McNary. “We incorporate this high level of reliability in our automated storage platforms to improve system uptime for the life science market.”

Built-in Dynamic Storage Optimization technology allocates storage space whenever samples are loaded, eliminating the need to predefine the mix of sample containers.

High-density trays increase tube storage up to 65% in the same footprint versus 96-tube racks. A high-throughput configuration can process over 100,000 tube picks per day.

The new standardized sample storage platform consists of the following components:
• SampleStore™ II system: for dry powder, small molecule, and DNA samples from room temperature to -20° C with 300,000- to over 10 million-tube storage capacity
• BioStore™ II system: for biological sample storage to -80° C with 700,000- to 5 million-tube storage capacity
• Strata™ automated control software: easy-to-operate and configure icon-based interface with mobile device accessibility. Simple integration with IT/LIMS systems, plus intelligent diagnostics enhances reliability.

“We’ve established a new benchmark for automated sample storage by offering the best user experience, highly flexible configuration, and ultra-reliable operation,” said McNary. “This ensures our customers can meet the changing needs of their applications – from compound storage for drug discovery to DNA, tissue, and blood serum storage for biobanking.”

The company said the first commercial systems are being installed in customer facilities and that orders can be placed immediately with Brooks’ sales representatives.

“Ask Brooks” to Provide Automated Sample Storage Expertise
Brooks also announced that it has launched Ask Brooks (http://www.brooks.com/ask-brooks) as part of a new strategic advisory services offering. The Web portal will allow automated sample storage users to question Brooks’ experts about any problems or issues they are facing.

“With over 250 storage systems in place, over 1 billion samples under management, and the industry’s largest engineering staff, we are uniquely qualified to answer tough questions and solve difficult problems,” McNary said. “We encourage sample storage professionals to use the new Web portal when they face challenging applications.”

Users simply type their questions into the form on the Ask Brooks portal and Brooks’ experts will promptly respond.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
New Cancer Drug Target in Dual-Function Protein
Scientists at The Scripps Research Institute (TSRI) have identified a protein that launches cancer growth and appears to contribute to higher mortality in breast cancer patients.
Penn State, TB Alliance, and GSK Partner To Discover New Treatments For TB
A new collaboration between TB Alliance, GSK, and scientists in the Eberly College of Science seeks to find new small molecules that can be used to create antibiotics in the fight against tuberculosis (TB).
Molecular Map Provides Clues To Zinc-Related Diseases
Mapping the molecular structure where medicine goes to work is a crucial step toward drug discovery against deadly diseases.
Platelets are the Pathfinders for Leukocyte Extravasation During Inflammation
Findings from the study could help in the prevention and treatment of inflammatory pathologies.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
New Method Opens Door to Development of Many New Medicines
Findings from TSRI reveal human proteins are better drug targets than previously thought.
Diagnosing Systemic Infections Quickly, Reliably
Team develop rapid and specific diagnostic assay that could help physicians decide within an hour whether a patient has a systemic infection and should be hospitalized for aggressive intervention therapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Blood Test That Detects Early Alzheimer’s Disease
A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy.
A New Approach to Chemical Synthesis
Communesins, originally found in fungus, could hold potential as cancer drugs.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!